Mounjaro®
Starting from £179.99/mo
Start journey Learn moreAt 0.5mg, Wegovy is a stepping-stone dose, not a treatment target — clinical trials tested the 2.4mg maintenance dose, where average weight loss reached around 15% of body weight over 68 weeks. How much weight you lose on 0.5mg specifically depends on where you are in the titration schedule and how long you stay there. Wegovy (semaglutide) is a prescription-only medicine, so the journey from this early dose toward the maintenance level is guided by a prescriber who reviews your response and tolerance at each stage. For a full picture of what the evidence says at higher doses, our overview of Wegovy weight loss results walks through the trial data across the full schedule.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The landmark evidence for Wegovy comes from the STEP 1 trial, published in the New England Journal of Medicine, which followed adults with obesity over 68 weeks. Participants taking semaglutide 2.4mg alongside lifestyle support lost an average of around 15% of their body weight. That figure is widely quoted — and it applies to the maintenance dose, not 0.5mg.
The 0.5mg dose is the second rung of the titration ladder. Treatment starts at 0.25mg for four weeks to let the body adjust, and if you want to understand how much weight you can lose on 0.25mg Wegovy, that starting phase is worth reading about before considering what comes next. Then it moves to 0.5mg for a further four weeks before the prescriber considers stepping up. Its job is to reduce early nausea and settle the gut, not to produce the weight loss that happens at 1.7mg or 2.4mg. Some people do notice their appetite shifting even at this stage (slower gastric emptying is already active) but the clinical trial was not designed to measure weight loss at sub-therapeutic doses in isolation.
For context on how results change as the dose increases, the 1mg dose page sets out what happens at the next step, and the full picture at the standard maintenance level is covered in the 2.4mg results page. The honest answer to how much weight you lose on 0.5mg Wegovy is: it varies, it's early, and the prescriber's guidance on how long you stay there matters more than the number on the scale right now.
UK private pricing for Wegovy is structured per pen, per month, and varies between providers and by dose. Following Eli Lilly's list-price increase in September 2025 for tirzepatide, the wider market adjusted; Wegovy pricing from private providers typically falls in a range of roughly £149 to £375 per month, hedged by dose and supplier, as widely reported. The 0.5mg phase represents roughly weeks five to eight of treatment, so for most people it's a short window in a longer programme, worth understanding in context rather than in isolation.
What matters more than the per-pen figure is what any quoted price actually includes. Some providers list a medicine price and then add consultation fees, prescription charges, or delivery costs separately. Others charge for dose-review calls or ongoing clinical support as an add-on. When comparing costs, it takes under a minute to check whether a pharmacy appears on the GPhC register, that verification step costs nothing and tells you whether the dispensing pharmacy is properly regulated.
At nume, one transparent price covers the free consultation, the prescription, the treatment itself, and free next-working-day delivery by DPD. There are no subscription traps and no auto-renewals. Every repeat order goes back to a prescriber for clinical re-review. We're not the cheapest option (that's a deliberate choice) because the clinical infrastructure behind each order is part of what you're paying for. For a fuller breakdown of what Wegovy private treatment costs in the UK, the Wegovy price page covers the market context in detail.
Wegovy is a prescription-only medicine. That means the only legal route to it in the UK is a prescription issued following a proper clinical assessment, at 0.5mg, at 2.4mg, or anywhere on the schedule. The MHRA has warned publicly about counterfeit weight-loss pens sold online and via social media, some containing insulin rather than semaglutide, with real harm resulting. Prices far below the market range, sellers who don't ask for any clinical information, and "discount codes" offered by unverified accounts are all red flags worth taking seriously.
For a medicine that works by changing how your body handles appetite and digestion, the right questions are clinical ones: is this the right treatment for me, at this dose, given my health history? Anyone considering whether to move up the titration schedule may also find it useful to read about how much weight you can lose on Wegovy 1.7mg, since that dose sits just before the final maintenance step and gives a clearer sense of what the programme builds toward. Suspected counterfeit sellers can be reported at the MHRA's Yellow Card service. The Wegovy treatment page sets out how the full titration schedule works and what clinical oversight looks like at each stage.
If you're ready to find out whether Wegovy is clinically suitable for you, speak to our prescribers, the consultation is free, and a named clinician reviews it the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.